WuXi PharmaTech Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (25)

Latest Posts

About This Stock More About This Stock
Week In Review: Suzhou's MabSpace Raises $15 Million For Antibody Program
Article By: ChinaBio® Today
Saturday, October 31, 2015 1:39 PM EST
WuXi PharmaTech has formed a partnership with Gilead Sciences under which WuXi will equip and operate a dedicated lab in Shanghai for Gilead's small-molecule new chemical entities.
In this article: LLY, WX, SVA
Read
Week In Review: Beijing's Beigene Plans $100 Million IPO In The US
Article By: ChinaBio® Today
Saturday, October 24, 2015 12:01 PM EST
Beigene, a Beijing biopharma, filed to raise $100 million in a US IPO. The company develops novel, molecularly targeted and immuno-oncology drugs to treat cancer.
In this article: LLY, WX, ABBV
Read
Week In Review: Innovent And Lilly Sign $1 Billion Cancer Deal
Article By: ChinaBio® Today
Sunday, October 18, 2015 10:58 PM EST
Innovent Biologics of Suzhou and Eli Lilly expanded their 10-year collaboration formed in March this year, granting Lilly ex-China rights to three new anti-PD-1 cancer drugs developed by Innovent.
In this article: LLY, WX, HCM
Read
Week In Review: Roche Buys China-Backed GeneWEAVE For $425 Million
Article By: ChinaBio® Today
Sunday, August 16, 2015 3:41 AM EST
Roche will pay $190 million up front and up to $235 million in milestones. GeneWEAVE’s Smarticles technology develops innovative molecular diagnostics that identify multidrug-resistant organisms.
In this article: RHHBY, WX
Read
Week In Review: WuXi Healthcare Ventures II Files For $250 Million Fund
Article By: ChinaBio® Today
Saturday, July 18, 2015 3:10 PM EST
Cayman Islands-based WuXi Healthcare Ventures Fund II, L.P. has filed paperwork with the US SEC for a $250 million life sciences venture fund.
In this article: AXN, WX
Read

Latest Tweets for $WX

No tweets yet!